From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence.
Overview
- Oncology Department, Institut de Cancérologie Strasbourg Europe,17 Rue Albert Calmette, Strasbourg, 67200 France
- Neurosurgery Department, Hôpitaux Universitaires de Strasbourg,1 Avenue Molière, Strasbourg, 67200 France
- Neuro-Radiology Department, Hôpitaux Universitaires de Strasbourg,1 Avenue Molière, Strasbourg, 67200 France
- Pharmaceutic Department, Institut de Cancérologie Strasbourg Europe,17 Rue Albert Calmette, Strasbourg, 67200 France
- Radiotherapy Department, Centre d’Oncologie du Pays Basque, 83 Avenue du 14 Avril 1814, Bayonne, 64100 France
- Radiotherapy Department, Institut de Cancérologie Strasbourg Europe,17 Rue Albert Calmette, Strasbourg, 67200 France
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
No dataset and no data link were found in the paper.
Code and data availability statement
The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- it says that the data are available on request
- it says that the code is available on request
Read it in the paper: doi.org/10.1007/s11060-026-05635-y.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 2, 28 September 2026
- Publisher: n/a → Springer Science+Business Media
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 11 authors, 6 keywords, 15 MeSH terms, 49 references.
Cite
This paper
Barbe-Richaud, J.-B., Cebula, H., Todeschi, J., Santin, M. d. N., Baloglu, S., Schott, R., Cotton, M., Blouet, A., Bobin, M., Noël, G., & Somme, L. (2026). From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence. Journal of neuro-oncology, 178(3), 73. https://
BibTeX
@article{barberichaud202
author = {Barbe-Richaud, Jean-Baptiste and Cebula, Hélène and Todeschi, Julien and Santin, Marie des Neiges and Baloglu, Seyyid and Schott, Roland and Cotton, Mathieu and Blouet, Aurélien and Bobin, Maxime and Noël, Georges and Somme, Laura},
title = {{From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence}},
journal = {Journal of neuro-oncology},
year = {2026},
month = jun,
volume = {178},
number = {3},
pages = {73},
publisher = {Springer Science+Business Media},
issn = {0167-594X},
doi = {10.1007/
url = {https://
pmid = {42334687},
pmcid = {PMC13290778}
}
RIS
TY - JOUR
AU - Barbe-Richaud, Jean-Baptiste
AU - Cebula, Hélène
AU - Todeschi, Julien
AU - Santin, Marie des Neiges
AU - Baloglu, Seyyid
AU - Schott, Roland
AU - Cotton, Mathieu
AU - Blouet, Aurélien
AU - Bobin, Maxime
AU - Noël, Georges
AU - Somme, Laura
TI - From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence
T2 - Journal of neuro-oncology
J2 - J Neurooncol
PY - 2026
DA - 2026/
VL - 178
IS - 3
SP - 73
SN - 0167-594X
PB - Springer Science+Business Media
DO - 10.1007/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1007/
"type": "article-journal",
"title": "From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence",
"container-title": "Journal of neuro-oncology",
"author": [
{
"family": "Barbe-Richaud",
"given": "Jean-Baptiste"
},
{
"family": "Cebula",
"given": "Hélène"
},
{
"family": "Todeschi",
"given": "Julien"
},
{
"family": "Santin",
"given": "Marie des Neiges"
},
{
"family": "Baloglu",
"given": "Seyyid"
},
{
"family": "Schott",
"given": "Roland"
},
{
"family": "Cotton",
"given": "Mathieu"
},
{
"family": "Blouet",
"given": "Aurélien"
},
{
"family": "Bobin",
"given": "Maxime"
},
{
"family": "Noël",
"given": "Georges"
},
{
"family": "Somme",
"given": "Laura"
}
],
"container-title-short":
"volume": "178",
"issue": "3",
"page": "73",
"DOI": "10.1007/
"PMID": "42334687",
"PMCID": "PMC13290778",
"ISSN": "0167-594X",
"publisher": "Springer Science+Business Media",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
23
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1016/j.cell.2026.05.026 [code]
- The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM.Journal: CellIn common: other condition, 6 references
- [2] doi:10.1158/1078-0432.ccr-25-4419 [code]
- Framework for Statistical Parametric Mapping of the Interactions between Glioblastoma Location, Treatment, Prognostic Variables, and Survival Using a Phase III Trial.Journal: Clinical cancer research : an official journal of the American Association for Cancer ResearchIn common: clinical / translational, other condition, 5 references
- [3] doi:10.1038/s12276-026-01801-4 [code]
- Putative glioblastoma origin-like cells in the subventricular zone: isolation and characterization.Journal: Experimental & molecular medicineIn common: other condition, 4 references
- [4] doi:10.1016/j.xcrm.2026.102850 [code]
- Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma.Journal: Cell reports. MedicineIn common: clinical / translational, other condition, 4 references
- [5] doi:10.1080/17501911.2026.2691031
- Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis.Journal: EpigenomicsIn common: other condition, 4 references
- [6] doi:10.1371/journal.pone.0351405 [code]
- Unimodal vs. multimodal deep learning for non-invasive MGMT promoter methylation prediction in glioblastoma: A systematic evaluation on the BraTS 2021 dataset.Journal: PloS oneIn common: other condition, 4 references
- [7] doi:10.1038/s41467-026-72258-2
- Mapping glioblastoma's isoform diversity using long-read single-cell analysis.Journal: Nature communicationsIn common: other condition, 3 references
- [8] doi:10.1038/s41467-026-72545-y [code]
- Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study.Journal: Nature communicationsIn common: clinical / translational, other condition, 3 references
- [9] doi:10.1038/s41698-026-01475-1 [code]
- Radiomics model integrating MRI and ECV enhances prediction accuracy for progression in high-grade glioma.Journal: NPJ precision oncologyIn common: clinical / translational, other condition, 3 references
- [10] doi:10.1172/jci195639
- Therapeutic delivery of microRNAs discovered to target deregulated glioblastoma pathways inhibits tumor growth in mice.Journal: The Journal of clinical investigationIn common: other condition, 3 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.